Skip to main content
DanCann Pharma A/S logo

DanCann Pharma A/S — Investor Relations & Filings

Ticker · DANCAN ISIN · DK0061410487 LEI · 549300KLXQ6IC2YUUB58 SPGR Wholesale and retail trade
Open in API
Filings indexed 2 across all filing types
Latest filing 2022-11-17 Capital/Financing Update
Country DK Denmark
Listing SPGR DANCAN

About DanCann Pharma A/S

https://www.dancann.com/

DanCann Pharma A/S is a biopharmaceutical company specializing in cannabinoid-based medicines. As a vertically integrated entity, it handles the discovery, development, production, and distribution of medical cannabis products. The company's core mission is to improve the quality of life for patients by providing regulated cannabinoid treatments in various formulations and delivery formats. A key focus is on pain management and the education of medical practitioners to support the broader adoption of cannabinoid-based therapies.

Recent filings

Filing Released Lang Actions
Approval of Supplementary Prospectus No. 1 for DANCANN PHARMA A/S; Share certificates
Capital/Financing Update Classification · 95% confidence The document is a 'Supplement to the Prospectus' related to a capital raise or securities offering. It details updates to a previously filed prospectus, including the incorporation of interim financial statements and new significant agreements. Since it relates to the formal documentation of a securities offering/prospectus, it falls under the category of capital/financing updates.
2022-11-17 English
Approval of prospectus for DANCANN PHARMA A/S; Share certificates
Regulatory Filings Classification · 95% confidence The document is a formal 'EU Growth Prospectus' for DanCann Pharma A/S, dated October 2022. It details an offer to subscribe for units (shares and warrants), includes regulatory approval from the Danish Financial Supervisory Authority, and provides comprehensive information on the company's business, risk factors, and financial history. Prospectuses are regulatory documents issued in connection with capital raising activities. Among the provided categories, 'Regulatory Filings' (RNS) is the most appropriate fallback for a prospectus that does not fit into specific categories like 10-K or IR, as it is a formal regulatory disclosure document.
2022-10-27 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.